Negara: Selandia Baru
Bahasa: Inggris
Sumber: Medsafe (Medicines Safety Authority)
Cefuroxime sodium 789mg equivalent to 750 mg cefuroxime;
Viatris Limited
Cefuroxime sodium 789 mg (equivalent to 750 mg cefuroxime)
750 mg
Powder for injection
Active: Cefuroxime sodium 789mg equivalent to 750 mg cefuroxime
Vial, glass, Ph Eur Type III or Type II clear glass,
Prescription
Prescription
Qilu Antibiotics Pharmaceutical Co Ltd
Package - Contents - Shelf Life: Vial, glass, Type II, 10 mL. Closure: bromobutyl rubber stopper, flip-off Al cap. Manufactured at Sinopharm only - 1 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Type I, 15 mL. Closure: bromobutyl rubber stopper, flip-off Al cap. Manufactured at Sinopharm only - 1 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Type II, 10 mL. Closure: chlorobutyl rubber stopper, flipoff Al cap. Manufactured at Reig Jofre only - 1 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Type II, 10 mL. Closure: chlorobutyl rubber stopper, flipoff Al cap. Manufactured at Reig Jofre only - 10 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Type II, 10 mL. Closure: bromobutyl rubber stopper, flip-off Al cap. Manufactured at Sinopharm only - 10 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Type I, 15 mL. Closure: bromobutyl rubber stopper, flip-off Al cap. Manufactured at Sinopharm only - 10 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
1998-12-02
Page 1 of 3 NEW ZEALAND CONSUMER MEDICINE INFORMATION CEFUROXIME FOR INJECTION _CEFUROXIME SODIUM INJECTION POWDER_ _250 MG, 750 MG, 1.5 G_ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about CEFUROXIME INJECTION. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using CEFUROXIME INJECTION against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CEFUROXIME INJECTION IS USED FOR CEFUROXIME INJECTION is an antibiotic used to treat a wide range of infections caused by bacteria and also to prevent infections during surgery. It can be given to adults and children. CEFUROXIME INJECTION contains the active ingredient cefuroxime sodium_._ It belongs to a group of medicines called cephalosporin antibiotics which targets a wide range of common bacteria. It works by killing the bacteria causing the infection or preventing cell growth. CEFUROXIME INJECTION is used in adults and children to treat bacterial infections of the: lungs or chest (bronchitis, pneumonia) ears, nose and throat (tonsillitis) urinary tract soft tissue bones and joints (osteomyelitis) female reproductive organs brain (meningitis) abdomen (peritonitis) blood (septicaemia) CEFUROXIME INJECTION can also be used to: treat gonorrhoea, a sexually transmitted infection prevent infections during various surgeries ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is available only with a doctor’s prescription. BEFORE YOU ARE GIVEN CEFUROXIME INJECTION _WHEN YOU MUST NOT BE _ _GIVEN IT_ DO NOT USE CEFUROXIME INJECTION IF YOU HAVE AN ALLERGY TO: any medic Baca dokumen lengkapnya
Page 1 of 11 NEW ZEALAND DATA SHEET CEFUROXIME FOR INJECTION 1. PRODUCT NAME Cefuroxime for injection, 250mg, 750 mg, 1.5 g, powder for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 263 mg, 789 mg or 1.578 g of cefuroxime sodium, equivalent to 250 mg, 750 mg or 1.5 g of cefuroxime. 3. PHARMACEUTICAL FORM Cefuroxime is a white to faintly yellow powder to which appropriate amounts of water are added to prepare an off-white suspension for intramuscular use or a yellow solution for intravenous administration. Variations in the intensity of this colour do not indicate any change in either the efficacy or safety of the product. 4. CLINICAL PARTICULARS _4.1 _ _THERAPEUTIC INDICATIONS_ Cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most _β-_lactamases and is active against a wide range of Gram-positive and Gram-negative organisms. It is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. Susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available (see section 5.1). INDICATIONS INCLUDE: Respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. Ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. Urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. Soft-tissue infections for example, cellulitis, erysipelas and wound infections. Bone and joint infections for example, osteomyelitis and septic arthritis. Obstetric and gynaecological infections, pelvic inflammatory diseases. Gonorrhoea particularly when penicillin is unsuitable. Other infections including septicaemia, meningitis and peritonitis. Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmo Baca dokumen lengkapnya